Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Short-term Investments (2022 - 2025)

CervoMed's Short-term Investments history spans 4 years, with the latest figure at $17.9 million for Q3 2025.

  • For Q3 2025, Short-term Investments fell 54.11% year-over-year to $17.9 million; the TTM value through Sep 2025 reached $17.9 million, down 54.11%, while the annual FY2024 figure was $29.9 million, N/A changed from the prior year.
  • Short-term Investments for Q3 2025 was $17.9 million at CervoMed, down from $25.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $38.9 million in Q3 2024 and bottomed at $3.0 million in Q1 2023.
  • The 4-year median for Short-term Investments is $22.7 million (2022), against an average of $22.9 million.
  • The largest annual shift saw Short-term Investments plummeted 86.81% in 2023 before it fell 28.14% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $12.4 million in 2022, then plummeted by 75.89% to $3.0 million in 2023, then skyrocketed by 900.16% to $29.9 million in 2024, then tumbled by 40.32% to $17.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Short-term Investments are $17.9 million (Q3 2025), $25.2 million (Q2 2025), and $24.7 million (Q1 2025).